Skip to main content
. 2020 Mar;8(5):225. doi: 10.21037/atm.2020.01.17

Table 2. Partial correlation analysis of variables associated with Framingham CVD risk score.

Variables All study subjects DM group
F-score F-score (adjusted by BMI) F-score (adjusted by HbA1C, FPG, 2-h PG) F-score (adjusted by LDL-C, TG) F-Score F-score (adjusted by BMI) F-score (adjusted by HbA1C, FPG, 2-h PG) F-score (adjusted by LDL-C, TG)
BMI (kg/m2) 0.222* 0.162 0.111 0.093 −0.077 0.076
HbA1C (%) 0.304** 0.141 0.082 −0.071 −0.166 −0.180
FPG (mg/dL) 0.282** 0.226* 0.157 0.081 0.073 −0.003
2-h PG 0.141 0.018 −0.035 −0.103 −0.223
Fasting insulin (µIU/mL) 0.130 0.089 0.132 0.112 −0.002 0.053 0.121 0.072
Fasting C-peptide (pmol/mL) 0.359** 0.362** 0.319* 0.363** 0.189 0.297* 0.180 0.319*
HOMA-IR 0.247* 0.184 0.369** 0.161 0.017 0.058 0.233 0.048
HOMA-beta −0.174 −0.138 0.068 −0.100 −0.100 0.037 0.046 0.076
LDL-C (mg/dL) 0.092 −0.048 −0.019 −0.113 −0.216 −0.050 −0.012
TG (mg/dL) 0.281** 0.287* 0.142 0.124 0.289* −0.058
hs-CRP (mg/L) 0.195 0.147 0.488** 0.175 −0.048 −0.045 0.104
apoA (mg/L) −0.412** −0.270 −0.155 −0.282 −0.326 −0.274 −0.021 −0.242
apoB (mg/L) 0.374* 0.145 0.199 0.138 0.249 0.020 0.197 0.042
IL-1beta (pg/mL) 0.314** 0.331*** 0.264* 0.302** 0.482*** 0.520*** 0.547** 0.480***

r value was calculated by the simple linear and partial rank correlation analysis. Partial correlation was adjusted with BMI, HbA1C, and FPG. *, P<0.05; **, P<0.01; ***, P<0.001. BMI, body mass index; HbA1c, hemoglobin A1c; FPG, fasting plasma glucose; 2-h PG, 2-hour post-load plasma glucose after 75 g oral glucose tolerance test; HOMA-IR, homeostasis model assessment-insulin resistance; LDL-C, low density lipoprotein cholesterol; TG, Triglyceride; hs-CRP, highly sensitive C-reactive protein; IL-1β, interleukin-1 β.